Broker tips: Haleon, Informa
Deutsche Bank upgraded Haleon to 'hold' but cut its price target to 310p, citing weak growth and strategic missteps. Haleon reduced its 2026 revenue growth forecast to 2.5%. Berenberg lowered its Informa target price to 1,005p, adjusting forecasts due to event rescheduling and cautious outlook on certain regions. Informa cut its revenue guidance to 3% but maintained double-digit EPS growth expectations.
How this was made

The 30-second read
Why it matters
Both firms face short‑term downside pressure from analyst downgrades, but the underlying businesses remain fundamentally sound.
Market read
Analyst downgrades and target cuts are fresh, actionable information for traders holding or watching HLN and INF.
What to watch
Potential cost‑saving initiatives and upcoming product launches may mitigate the impact of lower guidance.
Background
The article summarizes recent analyst actions on two UK‑based health‑care and events companies, focusing on target‑price cuts and guidance revisions.
Ticker impact
Deutsche Bank upgraded Haleon to hold and cut its price target to 310p after the company trimmed full‑year organic revenue growth guidance.
likely pressure as the market prices in weaker guidance and the target cut
The downgrade and target reduction are fresh, material signals that directly affect valuation expectations.
Market effects
Consumer healthcare and B2B events sectors may see broader scrutiny as analysts tighten forecasts.
European listed health‑care stocks could face heightened volatility in the UK market.
Limited to investors with exposure to HLN and INF; no macro‑level spillover.
Counterpoint
Despite the downgrades, both companies retain strong cash flows and could rebound if execution improves.
Key entities
- analystDeutsche Bank
Upgraded Haleon to hold and cut its price target.
- analystBerenberg
Trimmed Informa's target price and EPS forecasts.



